WallStreetZenWallStreetZen

NASDAQ: HZNP
Horizon Therapeutics Public Ltd Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for HZNP

Based on 9 analysts offering 12 month price targets for Horizon Therapeutics Public Ltd Co.
Min Forecast
$71.00-33.84%
Avg Forecast
$106.11-1.13%
Max Forecast
$144.00+34.18%

Should I buy or sell HZNP stock?

Based on 10 analysts offering ratings for Horizon Therapeutics Public Ltd Co.
Buy
Strong Buy
3 analysts 30%
Buy
0 analysts 0%
Hold
7 analysts 70%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HZNP stock forecasts and price targets.

HZNP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BMO Capital
Bottom 18%
18
HoldDowngradesN/AN/A2022-12-13
Guggenheim
Bottom 7%
7
HoldDowngrades$116.50+8.55%2022-12-13
SVB Leerink
Top 9%
92
HoldDowngrades$116.50+8.55%2022-12-13
Wells Fargo
Top 2%
99
HoldDowngrades$116.50+8.55%2022-12-13
Stifel Nicolaus
Bottom 19%
19
HoldDowngrades$116.50+8.55%2022-12-12
Piper Sandler
Top 14%
87
Strong BuyMaintains$110.00+2.50%2022-12-07Find out why
HC Wainwright & Co.
Top 27%
74
HoldInitiates Coverage On$74.00-31.05%2022-11-01
Morgan Stanley
Bottom 12%
12
Strong BuyMaintains$90.00-16.14%2022-08-04
Goldman Sachs
Top 1%
100
Strong BuyMaintains$144.00+34.18%2022-08-04
UBS
Bottom 10%
10
HoldDowngrades$71.00-33.84%2022-08-04

1 of 2

Forecast return on equity

Is HZNP forecast to generate an efficient return?
Company
N/A
Industry
14.55%
Market
28.66%

Forecast return on assets

Is HZNP forecast to generate an efficient return on assets?
Company
N/A
Industry
6.18%

HZNP earnings per share forecast

What is HZNP's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$5.41+137.28%
Avg 2 year Forecast
$6.74+195.61%
Avg 3 year Forecast
$7.70+237.72%
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HZNP revenue forecast

What is HZNP's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$4.1B+12.07%
Avg 2 year Forecast
$4.6B+27.78%
Avg 3 year Forecast
$4.9B+34.12%
HZNP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HZNP earnings growth forecast

How is HZNP forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
50.5%
Industry
24.03%
Market
19.49%
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HZNP revenue growth forecast

How is HZNP forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
10.84%
Industry
3.02%
Market
8.77%
HZNP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HZNP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HZNP vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
HZNP$107.32$106.11-1.13%Buy
BIIB$261.22$315.57+20.80%Buy
OGN$21.85$31.20+42.79%Buy
GRFS$6.65$13.00+95.49%Hold
TSVT$9.34$28.20+201.93%Strong Buy
View Top General Drug Manufacturer Stocks

Horizon Therapeutics Public Co Stock Forecast FAQ

Is Horizon Therapeutics Public Co Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: HZNP) stock is to Buy HZNP stock.

Out of 10 analysts, 3 (30%) are recommending HZNP as a Strong Buy, 0 (0%) are recommending HZNP as a Buy, 7 (70%) are recommending HZNP as a Hold, 0 (0%) are recommending HZNP as a Sell, and 0 (0%) are recommending HZNP as a Strong Sell.

If you're new to stock investing, here's how to buy Horizon Therapeutics Public Co stock.

What is HZNP's earnings growth forecast for 2023-2025?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's forecast annual earnings growth rate of 50.5% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.03%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 19.49%.

Horizon Therapeutics Public Co's earnings in 2023 is $521,482,000.On average, 9 Wall Street analysts forecast HZNP's earnings for 2023 to be $1,235,903,810, with the lowest HZNP earnings forecast at $1,135,386,679, and the highest HZNP earnings forecast at $1,368,403,664. On average, 7 Wall Street analysts forecast HZNP's earnings for 2024 to be $1,539,739,682, with the lowest HZNP earnings forecast at $1,297,584,776, and the highest HZNP earnings forecast at $1,720,213,621.

In 2025, HZNP is forecast to generate $1,759,049,785 in earnings, with the lowest earnings forecast at $1,473,489,755 and the highest earnings forecast at $2,170,256,228.

What is HZNP's revenue growth forecast for 2023-2025?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's forecast annual revenue growth rate of 10.84% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 3.02%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.77%.

Horizon Therapeutics Public Co's revenue in 2023 is $3,629,044,000.On average, 7 Wall Street analysts forecast HZNP's revenue for 2023 to be $929,123,699,787, with the lowest HZNP revenue forecast at $840,917,176,344, and the highest HZNP revenue forecast at $1,095,317,809,662. On average, 7 Wall Street analysts forecast HZNP's revenue for 2024 to be $1,059,334,276,058, with the lowest HZNP revenue forecast at $902,141,246,776, and the highest HZNP revenue forecast at $1,272,009,563,137.

In 2025, HZNP is forecast to generate $1,111,933,748,240 in revenue, with the lowest revenue forecast at $947,830,851,576 and the highest revenue forecast at $1,202,616,648,263.

What is HZNP's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: HZNP) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 6.18%.

What is HZNP's Price Target?

According to 9 Wall Street analysts that have issued a 1 year HZNP price target, the average HZNP price target is $106.11, with the highest HZNP stock price forecast at $144.00 and the lowest HZNP stock price forecast at $71.00.

On average, Wall Street analysts predict that Horizon Therapeutics Public Co's share price could fall to $106.11 by Dec 13, 2023. The average Horizon Therapeutics Public Co stock price prediction forecasts a potential downside of 1.13% from the current HZNP share price of $107.32.

What is HZNP's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's current Earnings Per Share (EPS) is $2.28. On average, analysts forecast that HZNP's EPS will be $5.41 for 2023, with the lowest EPS forecast at $4.97, and the highest EPS forecast at $5.99. On average, analysts forecast that HZNP's EPS will be $6.74 for 2024, with the lowest EPS forecast at $5.68, and the highest EPS forecast at $7.53. In 2025, HZNP's EPS is forecast to hit $7.70 (min: $6.45, max: $9.50).

What is HZNP's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: HZNP) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.